| 1. |
Calhoun DA,Jones D,Textor S,et al. Resistant hypertension:diagnosis,evaluation,and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension,2008,51:1403-1419.
|
| 2. |
中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版).中华结核和呼吸杂志,2012,35:9-12.
|
| 3. |
Witkowski A,Prejbisz A,Florczak E,et al. Effects of renal sympathetic denervation on blood pressure,sleep apnea course,and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension,2011,58:559-565.
|
| 4. |
Peppard PE,Young T,Palta M,et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med,2000,342:1378-1384.
|
| 5. |
中国医师协会高血压专业委员会,中华医学会呼吸病学分会睡眠呼吸障碍学组.阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识.中华高血压杂志,2012,20:1119-1124.
|
| 6. |
中华医学会呼吸病学分会睡眠呼吸疾病学组.睡眠呼吸暂停人群高血压患病率的多中心研究.中华结核和呼吸杂志,2007,30:894-897.
|
| 7. |
Lloberes P,Lozano L,Sampol G,et al. Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension. J Sleep Res,2010,19:597-602.
|
| 8. |
Bradley TD,Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet,2009,373:82-93.
|
| 9. |
涂学平,王念,胡克.慢性间歇缺氧引起高血压的发病机制.中国呼吸与危重监护杂志,2012,11:513-516.
|
| 10. |
Gjorup PH,Sadauskiene L,Wessels J,et al. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea:relation to blood pressure and severity of disease. Am J Hypertens,2007,20:44-52.
|
| 11. |
Clark DR,Ahmed MI,Calhoun DA. Resistant hypertension and aldosterone:an update. Can J Cardiol,2012,28:318-325.
|
| 12. |
Mcnicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea:overlaps in pathophysiology,systemic inflammation,and cardiovascular disease. Am J Respir Crit Care Med,2009,180:692-700.
|
| 13. |
Schmieder RE,Redon J,Grassi G,et al. ESH position paper:renal denervation-an interventional therapy of resistant hypertension. J Hypertens,2012,30:837-841.
|
| 14. |
Krum H,Schlaich M,Whitbourn R,et al. Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study. Lancet,2009,373:1275-1281.
|
| 15. |
Esler MD,Krum H,Sobotka PA,et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial):a randomised controlled trial. Lancet,2010,376:1903-1909.
|
| 16. |
Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months. Hypertension,2011,57:911-917.
|
| 17. |
Krum H,Schlaich MP,Sobotka PA,et al. Percutaneous renal denervation in patients with treatment-resistant hypertension:final 3-year report of the Symplicity HTN-1 study. Lancet,2014,383:622-629.
|
| 18. |
Esler MD,Bohm M,Sievert H,et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension:36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J,2014,35:1752-1759.
|
| 19. |
Bhatt DL,Kandzari DE,O’Neill WW,et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med,2014,370:1393-1401.
|
| 20. |
Böhm M. Medtronic Global SYMPLICITY Registry Shows Strong Safety Profile of the Symplicity(TM) Renal Denervation System. Six-Month Analysis of First 1,000 Patients Enrolled in Real-World Patient Registry;Proceedings of American College of Cardiology 2014 scientific sessions. Washington:cardio source,DC,USA,2014:29-31.
|
| 21. |
Shantha GP,Pancholy SB. Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea:a systematic review and meta-analysis. Sleep Breath,2015,19:29-34.
|
| 22. |
赵蒙蒙,谭雪雪,丁宁,等.肾动脉去交感神经射频消融与持续气道正压通气对高血压合并阻塞性睡眠呼吸暂停综合征的疗效比较.中华医学杂志,2013,93:1234-1237.
|
| 23. |
Yumino D,Redolfi S,Ruttanaumpawan P,et al. Nocturnal rostral fluid shift:a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation,2010,121:1598-1605.
|
| 24. |
Gaddam K,Pimenta E,Thomas SJ,et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension:a preliminary report. J Hum Hypertens,2010,24:532-537.
|
| 25. |
Koistinen HA,Zierath JR. Regulation of glucose transport in human skeletal muscle. Ann Med,2002,34:410-418.
|
| 26. |
Kjeldsen SE,Narkiewicz K,Oparil S,et al. Blood pressure lowering effect of renal sympathetic denervation or placebo?-building expectations for Symplicity-HTN 3. Blood Press,2013,22:279-281.
|
| 27. |
Persu A,Jin Y,Fadl EF,et al. Renal denervation after Symplicity HTN-3:an update. Curr Hypertens Rep,2014,16:460.
|
1/5
WeChat